SARS-CoV-2-IN-7
SARS-CoV-2-IN-7 inhibits viral replication with a nanomolar IC50 value (844 nM) in SARS-CoV-2-infected Vero E6 cells.
Product Specifications
CAS Number
[2570461-66-2]
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-7.html
Purity
98.84
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C1C2=CC=CC=C2[Se]N1C3=CC=CC(C(F)(F)F)=C3
Molecular Formula
C14H8F3NOSe
Molecular Weight
342.17
References & Citations
[1]Huff S, et al. Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors. J Med Chem. 2021 Sep 27:acs.jmedchem.1c00566.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1379652-01 0.5 mg (E-Coli)
Recombinant Mouse UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (B3gnt7), partial
Ask
View Details MBS1379652-02 0.05 mg (Baculovirus)
Recombinant Mouse UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (B3gnt7), partial
Ask
View Details MBS1379652-03 0.5 mg (Yeast)
Recombinant Mouse UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (B3gnt7), partial
Ask
View Details MBS1379652-04 0.05 mg (Mammalian-Cell)
Recombinant Mouse UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (B3gnt7), partial
Ask
View Details